SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 3 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,419,000 | -19.1% | 2,512,705 | 0.0% | 0.77% | +26.1% |
| Q1 2022 | $2,990,000 | -63.5% | 2,512,705 | 0.0% | 0.61% | -47.2% |
| Q4 2021 | $8,191,000 | -27.1% | 2,512,705 | 0.0% | 1.16% | -8.1% |
| Q3 2021 | $11,232,000 | -9.4% | 2,512,705 | +10.5% | 1.26% | -10.2% |
| Q2 2021 | $12,398,000 | +6.1% | 2,274,831 | +45.6% | 1.40% | +26.9% |
| Q1 2021 | $11,688,000 | -31.1% | 1,562,500 | 0.0% | 1.11% | -56.5% |
| Q4 2020 | $16,953,000 | – | 1,562,500 | – | 2.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 881,450 | $5,677,000 | 1.32% |
| IFP Advisors, Inc | 50 | $1,000 | 0.00% |
| Ten Capital Wealth Advisors, LLC | 219 | $1,000 | 0.00% |